Capital International Inc’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-26,429
| Closed | -$1.09M | – | 308 |
|
|
2022
Q3 | $1.09M | Sell |
26,429
-8,184
| -24% | -$339K | 0.02% | 253 |
|
|
2022
Q2 | $2.07M | Sell |
34,613
-6,879
| -17% | -$410K | 0.03% | 223 |
|
|
2022
Q1 | $3.01M | Sell |
41,492
-58,206
| -58% | -$4.23M | 0.03% | 209 |
|
|
2021
Q4 | $8.38M | Sell |
99,698
-251,801
| -72% | -$21.2M | 0.08% | 172 |
|
|
2021
Q3 | $31.7M | Sell |
351,499
-47,682
| -12% | -$4.3M | 0.31% | 99 |
|
|
2021
Q2 | $38.1M | Sell |
399,181
-24,776
| -6% | -$2.36M | 0.34% | 102 |
|
|
2021
Q1 | $48.3M | Sell |
423,957
-61,909
| -13% | -$7.05M | 0.45% | 78 |
|
|
2020
Q4 | $67.3M | Buy |
485,866
+5,033
| +1% | +$697K | 0.62% | 54 |
|
|
2020
Q3 | $39.5M | Buy |
480,833
+2,975
| +0.6% | +$245K | 0.44% | 81 |
|
|
2020
Q2 | $37.4M | Buy |
477,858
+27,363
| +6% | +$2.14M | 0.46% | 81 |
|
|
2020
Q1 | $20M | Buy |
450,495
+7,835
| +2% | +$348K | 0.34% | 96 |
|
|
2019
Q4 | $18.9M | Sell |
442,660
-28,405
| -6% | -$1.21M | 0.26% | 105 |
|
|
2019
Q3 | $20.2M | Buy |
471,065
+396,300
| +530% | +$17M | 0.3% | 103 |
|
|
2019
Q2 | $4.75M | Buy |
74,765
+26,715
| +56% | +$1.7M | 0.33% | 81 |
|
|
2019
Q1 | $3.33M | Buy |
48,050
+4,109
| +9% | +$285K | 0.4% | 58 |
|
|
2018
Q4 | $1.91M | Sell |
43,941
-900
| -2% | -$39.1K | 0.26% | 83 |
|
|
2018
Q3 | $3.42M | Buy |
44,841
+10,801
| +32% | +$825K | 0.45% | 58 |
|
|
2018
Q2 | $2.62M | Sell |
34,040
-7,100
| -17% | -$546K | 0.4% | 57 |
|
|
2018
Q1 | $2.1M | Sell |
41,140
-2,100
| -5% | -$107K | 0.3% | 69 |
|
|
2017
Q4 | $2.01M | Sell |
43,240
-2,860
| -6% | -$133K | 0.3% | 75 |
|
|
2017
Q3 | $2.46M | Sell |
46,100
-6,600
| -13% | -$351K | 0.36% | 67 |
|
|
2017
Q2 | $3.27M | Sell |
52,700
-4,300
| -8% | -$267K | 0.47% | 54 |
|
|
2017
Q1 | $3.86M | Buy |
57,000
+9,900
| +21% | +$671K | 0.47% | 57 |
|
|
2016
Q4 | $3.31M | Buy |
47,100
+11,900
| +34% | +$837K | 0.41% | 62 |
|
|
2016
Q3 | $2.5M | Buy |
+35,200
| New | +$2.5M | 0.3% | 65 |
|